pubmed semaglutide Semaglutide (Wegovy)

Effects of Once-Weekly Semaglutide #Nephpearls #Cardiorenal FLOW https:// pubmed.ncbi.nlm.nih.gov/38785209/ SUSTAIN 6 https://pubmed.ncbi.nlm.nih.gov/27633186/ SUSTAIN 6 Posthoc https://pubmed.ncbi.nlm.nih.gov/39081763/

20.39

★★★★☆4.8 (126)

Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial

23.80

★★★★★4.9 (98)

Once-weekly semaglutide administered after laparoscopic sleeve gastrectomy: Effects on body weight, glycemic control, and measured nutritional metrics in Japanese patients having both obesity and type 2 diabetes

26.88

★★★★★5.0 (157)

Tirzepatide as Compared with Semaglutide for the Treatment of Obesity

29.48

★★★★★4.7 (84)

Weight-loss drugs are becoming more accessible, but are they always safe? Experts raise concerns about the misuse of semaglutide generics and the risks of unsupervised use. From side effects to long-term impact,

21.20

★★★★★4.9 (203)

Effects of Once-Weekly Semaglutide #Nephpearls #Cardiorenal FLOW https:// pubmed.ncbi.nlm.nih.gov/38785209/ SUSTAIN 6 https://pubmed.ncbi.nlm.nih.gov/27633186/ SUSTAIN 6 Posthoc https://pubmed.ncbi.nlm.nih.gov/39081763/

27.14

★★★★★5.0 (176)

Suboptimal therapeutic responses associated with semaglutide in type 2 diabetes and obesity: A meta-analysis of randomized controlled trials: Cell Reports Medicine

27.42

★★★★★4.8 (132)